- Home
- ARTW vs ACXP Comparison
ARTW vs ACXP Comparison
Compare ARTW & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- ACXP
- Stock Information
- Founded
- ARTW 1956
- ACXP 2017
- Country
- ARTW United States
- ACXP United States
- Employees
- ARTW N/A
- ACXP N/A
- Industry
- ARTW Industrial Machinery/Components
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- ACXP Health Care
- Exchange
- ARTW Nasdaq
- ACXP Nasdaq
- Market Cap
- ARTW 9.3M
- ACXP 8.4M
- IPO Year
- ARTW N/A
- ACXP 2021
- Fundamental
- Price
- ARTW $2.04
- ACXP $0.43
- Analyst Decision
- ARTW
- ACXP Strong Buy
- Analyst Count
- ARTW 0
- ACXP 2
- Target Price
- ARTW N/A
- ACXP $10.00
- AVG Volume (30 Days)
- ARTW 14.4K
- ACXP 18.4M
- Earning Date
- ARTW 07-07-2025
- ACXP 08-08-2025
- Dividend Yield
- ARTW N/A
- ACXP N/A
- EPS Growth
- ARTW N/A
- ACXP N/A
- EPS
- ARTW 0.14
- ACXP N/A
- Revenue
- ARTW $23,916,932.00
- ACXP N/A
- Revenue This Year
- ARTW N/A
- ACXP N/A
- Revenue Next Year
- ARTW N/A
- ACXP N/A
- P/E Ratio
- ARTW $40.12
- ACXP N/A
- Revenue Growth
- ARTW N/A
- ACXP N/A
- 52 Week Low
- ARTW $1.40
- ACXP $0.30
- 52 Week High
- ARTW $4.15
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- ARTW 59.35
- ACXP 47.99
- Support Level
- ARTW $1.73
- ACXP $0.52
- Resistance Level
- ARTW $2.00
- ACXP $0.63
- Average True Range (ATR)
- ARTW 0.12
- ACXP 0.09
- MACD
- ARTW 0.01
- ACXP 0.00
- Stochastic Oscillator
- ARTW 94.07
- ACXP 17.33
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.